EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Doing business as EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC
- GAITHERSBURG, MD 20879-3428
- emergentbiosolutions.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $2.4B
- Awards on record
- 7
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
- Headquarters
- GAITHERSBURG, MD 20879-3428
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEICNPVCR8DK7M8
- CAGE057Y1
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $2.4B
- Awards on record
- 7
- Top funding agencies
- Office of Assistant Secretary for Preparedness and Response · Department of the Army · National Institutes of Health
Awards
75A50123C00037
Recompete 18+ mo: Potential end Jul 29, 2033 (80 months away)MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES…
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $118.6M
- Period of performance
- Jul 31, 2023 – Jul 29, 2033
75N98026P00379
Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC.
Department of Health and Human Services · National Institutes of Health
- Obligated
- $11.2K
- Period of performance
- Apr 27, 2026 – Mar 31, 2027
75A50119C00071
Completed: Period of performance ended Sep 30, 2026ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $857.6M
- Period of performance
- Aug 30, 2019 – Sep 30, 2026
HHSO100201600030C
Completed: Period of performance ended Sep 29, 2026IGF::OT::IGF
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $1.4B
- Period of performance
- Sep 30, 2016 – Sep 29, 2026
HHSO100201700001C
Completed: Period of performance ended Jun 3, 2024IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $33M
- Period of performance
- Sep 15, 2017 – Jun 3, 2024
W81XWH19C0193
Completed: Period of performance ended Feb 29, 2024CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM.
Department of Defense · Department of the Army
- Obligated
- $5.7M
- Period of performance
- Sep 26, 2019 – Feb 29, 2024
HHSO100201500004C
Completed: Period of performance ended Jul 31, 2019IGF::OT::IGF FOR OTHER FUNCTIONSTHIS CONTRACT IS FOR THE ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $43.8M
- Period of performance
- Mar 23, 2015 – Jul 31, 2019
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75A50123C00037 MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES… | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541714 · AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $118.6M | Jul 31, 2023 – Jul 29, 2033 | Recompete 18+ mo: Potential end Jul 29, 2033 (80 months away) |
75N98026P00379 HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | Department of Health and Human Services · National Institutes of Health | 541714 · Q301REFERENCE LABORATORY TESTING | $11.2K | Apr 27, 2026 – Mar 31, 2027 | Recompete < 6 mo: Potential end Mar 31, 2027 (4 months away)AI brief for award 75N98026P00379Bid team for the recompete of award 75N98026P00379 |
75A50119C00071 ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325414 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $857.6M | Aug 30, 2019 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
HHSO100201600030C IGF::OT::IGF | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541711 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $1.4B | Sep 30, 2016 – Sep 29, 2026 | Completed: Period of performance ended Sep 29, 2026 |
HHSO100201700001C IGF::OT::IGF - ADVANCING STABILIZED ISOAMYL NITRITE FOR INTRANASAL TREATMENT OF CYANIDE EXPOSURE | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541711 · AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $33M | Sep 15, 2017 – Jun 3, 2024 | Completed: Period of performance ended Jun 3, 2024 |
W81XWH19C0193 CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM. | Department of Defense · Department of the Army | 541715 · AN93R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT) | $5.7M | Sep 26, 2019 – Feb 29, 2024 | Completed: Period of performance ended Feb 29, 2024 |
HHSO100201500004C IGF::OT::IGF FOR OTHER FUNCTIONSTHIS CONTRACT IS FOR THE ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909 | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541711 · AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $43.8M | Mar 23, 2015 – Jul 31, 2019 | Completed: Period of performance ended Jul 31, 2019 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 4 awards
- Total awarded
- $726,112
- By phase
- SBIR Phase I: 2
- STTR Phase I: 1
- STTR Phase II: 1
- By agency
- Department of Defense: 4
- By year
- 2001: 1
- 2000: 1
- 1999: 1
- 1997: 1
Awards (most recent first)
Development of a Microbead Whole Cell Delivery System for Oral Immunization against traveler's diarrhea
SBIR Phase I · Department of Defense (Army) · 2001 · $68,112
Not Available
STTR Phase II · Department of Defense (Army) · 2000 · $459,600
Research partner: JOHNS HOPKINS UNVIERSITY
Development of a Prototype Multivalent, Oral Vaccine for Traveler's Diarrhea
STTR Phase I · Department of Defense (Army) · 1999 · $100,000
Research partner: Johns Hopkins University
Synthesis and Chararterization of Therapeutics for the Modulation of Bacterial Virulence
SBIR Phase I · Department of Defense (Defense Advanced Research Projects Agency) · 1997 · $98,400
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
- 325412Pharmaceutical Preparation ManufacturingSmall business under this code’s size standard
- 541713Research and Development in NanotechnologySmall business under this code’s size standard
SAM.gov reports this entity as small under 3 of 3 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
